These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24111823)

  • 1. Clinical trial simulation to assist in COPD trial planning and design with a biomarker-based diagnostic: when to pull the trigger?
    Gold DL; Dawson M; Yang H; Parker J; Gossage DL
    COPD; 2014 Apr; 11(2):226-35. PubMed ID: 24111823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in chronic obstructive pulmonary disease.
    Rosenberg SR; Kalhan R
    Transl Res; 2012 Apr; 159(4):228-37. PubMed ID: 22424427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in chronic obstructive pulmonary disease.
    Sin DD; Vestbo J
    Proc Am Thorac Soc; 2009 Sep; 6(6):543-5. PubMed ID: 19741266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker discovery in asthma and COPD by proteomic approaches.
    Rossi R; De Palma A; Benazzi L; Riccio AM; Canonica GW; Mauri P
    Proteomics Clin Appl; 2014 Dec; 8(11-12):901-15. PubMed ID: 25186471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD.
    Bazeghi N; Gerds TA; Budtz-Jørgensen E; Hove J; Vestbo J
    Respir Med; 2011 Sep; 105(9):1338-44. PubMed ID: 21530214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD Foundation.
    Rennard S; Thomashow B; Crapo J; Yawn B; McIvor A; Cerreta S; Walsh J; Mannino D
    COPD; 2013 Jun; 10(3):378-89. PubMed ID: 23713598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood specimen biomarkers of inflammation, matrix degradation, angiogenesis, and cardiac involvement: a future useful tool in assessing clinical outcomes of COPD patients in clinical practice?
    Kristan SS
    Arch Immunol Ther Exp (Warsz); 2013 Dec; 61(6):469-81. PubMed ID: 23703244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phenotypes in chronic obstructive pulmonary disease].
    Corhay JL; Schleich F; Louis R
    Rev Med Liege; 2014; 69(7-8):415-21. PubMed ID: 25158382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.
    Goh F; Shaw JG; Savarimuthu Francis SM; Vaughan A; Morrison L; Relan V; Marshall HM; Dent AG; O'Hare PE; Hsiao A; Bowman RV; Fong KM; Yang IA
    Expert Rev Respir Med; 2013 Dec; 7(6):593-605. PubMed ID: 24160750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1.
    Coxson HO; Leipsic J; Parraga G; Sin DD
    Am J Respir Crit Care Med; 2014 Jul; 190(2):135-44. PubMed ID: 24873985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
    Chen H; Wang D; Bai C; Wang X
    J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
    Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
    Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.
    Casado B; Iadarola P; Luisetti M; Kussmann M
    Expert Rev Proteomics; 2008 Oct; 5(5):693-704. PubMed ID: 18937559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in obstructive respiratory diseases: an update.
    Braido F; Bagnasco D; Scichilone N; Santus P; Solidoro P; Di Marco F; Corsico A; Canonica GW
    Panminerva Med; 2012 Jun; 54(2):119-27. PubMed ID: 22525566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice.
    Miravitlles M; Soler-Cataluña JJ; Calle M; Soriano JB
    Eur Respir J; 2013 Jun; 41(6):1252-6. PubMed ID: 23060631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic obstructive pulmonary disease (COPD) phenotypes].
    Mazur W; Laitinen T; Kinnula V
    Duodecim; 2013; 129(2):127-36. PubMed ID: 23577576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for biomarkers in chronic obstructive pulmonary disease: current status.
    Nicholas BL
    Curr Opin Pulm Med; 2013 Mar; 19(2):103-8. PubMed ID: 23361193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome.
    Roche N; Rabbat A; Zureik M; Huchon G
    Curr Opin Pulm Med; 2010 Mar; 16(2):112-7. PubMed ID: 20019614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances.
    Carolan BJ; Sutherland ER
    J Allergy Clin Immunol; 2013 Mar; 131(3):627-34; quiz 635. PubMed ID: 23360757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease.
    Verrills NM; Irwin JA; He XY; Wood LG; Powell H; Simpson JL; McDonald VM; Sim A; Gibson PG
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1633-43. PubMed ID: 21471098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.